FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1024-1025 April 3, 1997 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pilote, L. PubMed Citation

To the Editor: In their interesting analysis of the use of angiography and coronary revascularization in the first Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries trial (GUSTO-1), Pilote et al. (Oct. 17 issue)¹ conclude that there is an excessive use of arteriography and revascularization after myocardial infarction in U.S. patients, many of whom do not clearly require such procedures, as well as an inappropriately low use of these procedures in higher-risk patients who are most likely to benefit from selective revascularization. These data will not surprise any sophisticated physician.

Not fully emphasized in the discussion . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.